CommercialCoverageMedium impact
07.08.03i, Medical and Surgical Treatment of Temporomandibular Joint Disorder
Independence Blue Cross·Oral & Maxillofacial Surgery, ENT (Ear, Nose & Throat), General Surgery +1 more·Medical Policy
Effective date
Aug 6, 2025
We identified it
Jun 19, 2026
Summary
IBX Commercial has reissued their Medical Policy 07.08.03i regarding Medical and Surgical Treatment of Temporomandibular Joint Disorder. This is a policy reissue that will take effect August 6, 2025, potentially updating coverage criteria, billing requirements, or documentation standards for TMJ treatments.
Action Required
By August 6, 2025: Billing team must review the complete IBX policy 07.08.03i at the provided URL to identify specific changes to TMJ disorder coverage, prior authorization requirements, or billing guidelines. Update billing procedures and provider documentation requirements based on the full policy content.